 |
Imatinib |
|---|---|
| Trade Name | Gleevec |
| Orphan Indication | Chronic myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2001-01-31 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corporation;59 Route 10;East Hanover, New Jersey, 07936 |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia